Qsemble Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
Qsemble Capital Management's RGEN Position: Q3 2026 in Review
Qsemble Capital Management sold out of Repligen (RGEN) in Q3 2026, closing a stake of 2,635 shares — an estimated $360K sold.
Qsemble Capital Management first reported a position in RGEN in Q2 2023 and held it in 7 quarters. The position peaked at $611K in Q4 2025. 403 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.
- Qsemble Capital Management reported no remaining Repligen position as of Q3 2026 after selling out during the quarter.
- Qsemble Capital Management sold 2,635 Repligen shares in Q3 2026, an estimated $360K.
- Qsemble Capital Management first reported a position in Repligen in Q2 2023 and held it in 7 quarters.
- Qsemble Capital Management's Repligen position peaked at $611K in Q4 2025.
- 403 funds tracked by Wall St. Rank held Repligen as of Q3 2026.
Based on Qsemble Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.